• A confidential regulatory dossier submitted to the FDA describing a manufacturer’s components, materials, and processes used in drugs or packaging systems.
  • Allows pharmaceutical customers to reference MPI’s DMF when filing their own applications, supporting faster review and validation of packaging components.
  • Often includes technical data, quality controls, and compliance documentation relevant to cGMP and safety expectations.